heidi hamm Archives
Releasing a brake that drives obesity and diabetes
Sep. 6, 2023—Vanderbilt researchers have uncovered a potential new way to help curb the rapidly rising worldwide prevalence of metabolic disorders, including obesity and diabetes.
Former Pharmacology chair Hardman remembered as gifted scientist, educator, mentor
Jul. 2, 2019—Joel Hardman, PhD, an internationally recognized scientist and educator who chaired the Department of Pharmacology at Vanderbilt University School of Medicine from 1975 to 1990, died June 30, 2019 in Hoosick Falls, New York, after a lengthy illness. He was 85.
Vanderbilt scientists report new modeling of brain signaling
Mar. 7, 2019—The release of neurotransmitters and hormones in the body is tightly controlled by complex protein machinery embedded in cell membranes.
Meet Vanderbilt’s first Academic Pathways fellows
Oct. 27, 2017—Seven outstanding Ph.D.’s with diverse backgrounds and experiences have come to Vanderbilt to pursue postdoctoral training with an eye toward academic careers.
Reducing antidepressants’ side effects
Nov. 23, 2016—Vanderbilt investigators have discovered how antidepressant medicines that block serotonin uptake can increase bleeding risk.
VUMC investigators honored by ASPET
Jan. 15, 2015—Vanderbilt's Heidi Hamm, Ph.D., and L. Jackson Roberts II, M.D., have been lauded by the American Society for Pharmacology and Experimental Therapeutics (ASPET).
Hamm’s lasting impact commended at Flexner Discovery Lecture
Jun. 19, 2014—In their introductions of Heidi Hamm, Ph.D., prior to her Flexner Discovery Lecture last week, Susan Wente, Ph.D., and P. Jeffrey Conn, Ph.D., recounted how early encounters with her influenced their careers. For Wente, associate vice chancellor for Research, senior associate dean of Biomedical Science and soon-to-be University Provost, it was a lecture that Hamm...
Pharmacology reached new heights on Hamm’s watch
Jun. 12, 2014—During her 13-year tenure as chair of Vanderbilt University’s Department of Pharmacology, Heidi Hamm, Ph.D., bolstered its international reputation, attracted 18 new faculty members and helped take it in new directions, such as drug discovery.
Hamm to deliver Discovery Lecture June 12
Jun. 5, 2014—Heidi Hamm, Ph.D., the Aileen M. Lange and Annie Mary Lyle Professor of Cardiovascular Research and an internationally known expert on G protein-mediated signaling, will deliver the next Flexner Discovery Lecture on Thursday, June 12.
VU researchers report G protein advancement that could lead to more effective drugs
Dec. 2, 2013—Thanks in part to a computer program named “Rosetta,” Vanderbilt University researchers are closer to understanding how the ubiquitous G protein is activated – a discovery that could lead to the design of more specific and effective drugs.
Hamm’s research honored by Dutch pharmacology society
Oct. 25, 2012—Heidi Hamm, Ph.D., chair of the Department of Pharmacology, has won the 2012 Ariens Award from the Dutch Pharmacological Society.
Nobel in Chemistry reveals VU ties that bind
Oct. 18, 2012—Several Vanderbilt researchers have collaborated with this year's Nobel Chemistry winners.
